MedTrace Logo

A Trial to Assess the Impact of Ascorbic Acid on Cardiac Surgeries Outcomes and Complications''

NCT03639519 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-08-21

No results posted yet for this study

Summary

this study is evaluating the safety and efficacy of ascorbic acid as a drug that can decrease inflammatory complications post surgical in addition to its impact on decreasing risk of arrhythmia and total opioid administration post operative

Conditions

  • Cardiothoracic Surgery

Interventions

DRUG

Ascorbic Acid 500Mg Chew Tab

Ascorbic acid will be administered at the night before surgery and will be continued for five days

OTHER

Carbonated orange beverage

The carbonated orange beverage will be administered at the night before surgery and will be continued for five days

Sponsors & Collaborators

  • El-Galaa Military Medical Complex

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-15
Primary Completion
2019-04-15
Completion
2019-08-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03639519 on ClinicalTrials.gov